Cargando…
Safety and Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Children Aged 2–5 Years in the United States
In a phase 4, randomized, placebo-controlled, double-blind, multicenter study, to assess the safety and immunogenicity of live, attenuated cholera vaccine PXVX0200 in children aged 2–5 years in the United States, 172 volunteers were randomized 6:1 to receive a single dose of 1 × 10(9) colony forming...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Tropical Medicine and Hygiene
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941807/ https://www.ncbi.nlm.nih.gov/pubmed/33319739 http://dx.doi.org/10.4269/ajtmh.20-0917 |